PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment. Israel E, Denlinger LC, Bacharier LB, LaVange LM, et al. J Allergy Clin Immunol 2021 Mar 2. pii: S0091-6749(21)00352.

Read + Share

Amedeo Smart

Independent Medical Education

Israel E, Denlinger LC, Bacharier LB, LaVange LM, et al. PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment. J Allergy Clin Immunol 2021 Mar 2. pii: S0091-6749(21)00352.
PMID: 33667479